Issuer Information

EDGAR: Contact Information

Name:

GENEOS Therapeutics, Inc.
Address:

660 WEST GERMANTOWN PIKE
SUITE LL110
PLYMOUTH MEETING, PENNSYLVANIA 19462
Phone:

(267) 440-4232

EDGAR: Other Information

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/Accession	Details	Fed. Exemptions	Notices
480803: 0001769177-23-000001	First Sale: 2023-03-31 Security Type(s): Equity Offer Amount: $9,999,996 Amount Sold: $4,999,998 Remaining: $4,999,998	06b	No Notices in EFD for this offering.
437332: 0001769177-22-000001	First Sale: 2022-03-21 Security Type(s): Equity Offer Amount: $25,000,000 Amount Sold: $17,249,984 Remaining: $7,750,016	06b	PA, TX,
355107: 0001769177-20-000003	First Sale: 2020-11-12 Security Type(s): Equity Offer Amount: $11,999,995 Amount Sold: $10,399,998 Remaining: $1,599,997	06b	MA, PA, TX, VA, WI,
305861: 0001769177-19-000001	First Sale: 2019-02-21 Security Type(s): Equity, Warrants to purchase Common Stock will be issued to M.M. Dillon & Co. and designees of Brookline Capital Markets in addition to any fees paid for commissions and financial advice. Offer Amount: $10,499,993 Amount Sold: $4,499,998 Remaining: $5,999,995	06b	No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.